CorestemChemon

CorestemChemon Inc. is a global biotechnology company focused on developing stem cell–based therapies and advancing drug discovery through innovative research. Its biopharmaceutical division is dedicated to treating rare and neurodegenerative diseases, while its nonclinical CRO division provides essential preclinical testing services such as toxicity and efficacy evaluation. Together, these capabilities position the company at the forefront of regenerative medicine and early-stage drug development.